Disclosure - Responsible Transparency / 2023
Disclosures by KEFEA Members:
(Also click on the following hyperlink for the payments to HCPs & HCOs) – Represented by ALECTOR PHARMACEUTICALS
(Also click on the following hyperlink for the Methodology note)
(Also click on the following hyperlink for the Methodological note and the Payments to HealthCare Professionals Main Page)
(Also click on the following hyperlink for the Methodological note)
(Also click on the following hypelink for the Methodology Statement and the Disclosure Report for Patient Organizations. The Methodoly Statement for Patient Organizations is available here)
(Also click on the following hyperlink for the Methodological note)
Also click on the following hyperlink for the Methodological note)
Disclosures by other EFPIA members operating in Cyprus*:
- LIFEPHARMA (Z.A.M.) LTD representing ABBVIE
- G.A. STAMATIS & CO. LTD representing Roche (Hellas) S.A.
- C.G. PAPALOISOU representing Merck and for the payments to CGP to POs
- C.G. PAPALOISOU representing Other and here for the payments to CGP to HCPs & HCOs
- Varnavas Hadjipanayis Ltd representing Novo Nordisk
- CPO Ltd representing Boehringer Ingelheim
* Hypertext links in this section of the website will direct you to websites containing the disclosure of transfers of value as required by the KEFEA Code of Conduct. These websites are not under the control of KEFEA. When you activate any of these, you will leave this website. KEFEA accepts no responsibility or liability for the accuracy of the content of any such websites and makes no representation or warranty (express or implied) as to the information contained therein.’’